Eli Lilly and Company has become a key player in the production of tirzepatide, a groundbreaking drug for type 2 diabetes. Tirzepatide, a dual GIP and GLP-1 receptor agonist, showcases significant potential to improve https://finnianaxug764292.mpeblog.com/74542377/eli-lilly-s